Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-02-25 @ 2:34 AM
Study NCT ID:
NCT02795858
Status:
COMPLETED
Last Update Posted:
2025-02-19
First Post:
2016-06-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Sponsor:
Dana-Farber Cancer Institute
Organization: